After Geron's (GERN) stock price experienced a meteoric rise and equally spectacular fall in the second half of 2018, it appears as though the stock might finally be about to stabilize. After reaching an intra-day high of $6.99 (market cap of $1.29B) on 09/13/18, Johnson & Johnson-owned (JNJ) Janssen's announcement on 09/27/18 of its decision to terminate the collaboration agreement between the two companies caused stock price to plummet into the $1 range. After briefly dropping below $1.00/share in December 2018, Geron's stock has gradually climbed throughout 2019 and closed at